About Event

As the only industry-led meeting dedicated to preclinical and translational targeted oncology modeling, driven by case studies, enabling our audience to make informed clinical decisions – this is your must attend event in 2022

With 2022 being free to attend for drug developers and academics, now is your chance to gain exclusive insights, benchmark against your peers and shake hands with thought-leaders!

In collaboration with Sanofi, Merck, Amgen, Dana Farber Sanofi, this is the only case studies driven meeting dedicated to in vivo, in vitro experts to enhance their modelling techniques. Across 3 days, with 2 streams for preclinical and translational scientists respectively, you’ll:

https://tumor-models.com/wp-content/uploads/sites/65/2022/03/cropped-HW220228-Tumor-Models-For-for-Combination-Targeted-Oncology-Logo-ICON-ONLY.jpg

Learn how emerging platforms can complement your cell and tumor biology, giving you a much deeper understanding of the mouse model requirement

https://tumor-models.com/wp-content/uploads/sites/65/2022/03/cropped-HW220228-Tumor-Models-For-for-Combination-Targeted-Oncology-Logo-ICON-ONLY.jpg

Hear preclinical model 2.0 approach, giving you tips on which models to select for the most predictive readouts prior to first-in-human studies

https://tumor-models.com/wp-content/uploads/sites/65/2022/03/cropped-HW220228-Tumor-Models-For-for-Combination-Targeted-Oncology-Logo-ICON-ONLY.jpg

Delve into combination, targeted oncology’s challenges including tumor heterogeneity, safety, drug resistance and sensitivity helping you to refine clinical design

https://tumor-models.com/wp-content/uploads/sites/65/2022/03/cropped-HW220228-Tumor-Models-For-for-Combination-Targeted-Oncology-Logo-ICON-ONLY.jpg

Deep dive into translational biomarker identification to guide patient stratification in clinical programs

https://tumor-models.com/wp-content/uploads/sites/65/2022/03/cropped-HW220228-Tumor-Models-For-for-Combination-Targeted-Oncology-Logo-ICON-ONLY.jpg

Learn how to implement models which divulge into the natural history of your tumor

https://tumor-models.com/wp-content/uploads/sites/65/2022/03/cropped-HW220228-Tumor-Models-For-for-Combination-Targeted-Oncology-Logo-ICON-ONLY.jpg

Meet and network with selected CROs, model developers and academics to hear their latest platforms and form meaningful partnerships

Be part of this growing community this July to support your pipeline acceleration, and develop a novel, safe and efficacious treatments for patients in need!

 

As drug developers or academics, secure your free pass before they book up!

 

Want to learn more? Download the agenda here!